fb tracking

White House Aide Heidi Overton is the Wrong Choice for FDA Commissioner

WASHINGTON, D.C. – The U.S. Senate Committee on Health, Labor and Pensions has scheduled a vote on Wednesday, November 18 on the nomination of Heidi Overton to lead the U.S. Food and Drug Administration (FDA). Overton, a physician with additional training in public health and general preventive medicine, is the Deputy Assistant to the President for Domestic Policy at the White House. Robert Steinbrook, M.D., Health Research Group director for Public Citizen, issued the following statement:

“There are countless reasons for the Senate to reject Heidi Overton’s nomination for FDA Commissioner, starting with the White House aide’s lack of managerial experience and call for scientific journals to prioritize ‘conservative-based’ science. She opposes expanded access to medication abortion, and she supports splitting the proven measles, mumps, and rubella (MMR) vaccine into separate single disease shots in the midst of a devastating measles epidemic.

“The FDA needs a strong commissioner who stands for science and the integrity of the agency. Overton is the wrong choice for FDA Commissioner, and has done nothing to dispel the well-founded reasons to oppose her candidacy. The Senate HELP Committee must reject her nomination.”